Caitong International Asset Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$720 Sell
28
-25
-47% -$579 ﹤0.01% 1627
2026
Q1
$1.09K Buy
+53
New +$1.2K ﹤0.01% 1408
2025
Q4
– Sell
-676
Closed -$16.8K – 2280
2025
Q3
$16.8K Buy
676
+613
+973% +$13.2K 0.01% 793
2025
Q2
$1.45K Sell
63
-3,260
-98% -$75.5K ﹤0.01% 1482
2025
Q1
$74.6K Buy
3,323
+3,173
+2,115% +$73.7K 0.06% 368
2024
Q4
$2.93K Buy
+150
New +$2.97K ﹤0.01% 1115

Other funds holding PRVA

Caitong International Asset Management's PRVA Position: Q2 2026 in Review

Caitong International Asset Management reduced its Privia Health (PRVA) stake by 47% in Q2 2026, selling an estimated $579 and leaving 28 shares worth $720. The position accounts for ﹤0.01% of the portfolio, ranked #1627.

Caitong International Asset Management first reported a position in PRVA in Q4 2024 and has held it in 6 quarters since. The position peaked at $74.6K in Q1 2025. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Caitong International Asset Management held 28 shares of Privia Health worth $720 as of Q2 2026.
  • Caitong International Asset Management sold 25 Privia Health shares in Q2 2026, an estimated $579.
  • Privia Health made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1627 holding.
  • Caitong International Asset Management first reported a position in Privia Health in Q4 2024 and has held it in 6 quarters since.
  • Caitong International Asset Management's Privia Health position peaked at $74.6K in Q1 2025.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.